Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer
Clinical trial NCT03055312 · TERMINATED
Trial details
- NCT number
- NCT03055312
- Sponsor
- Sun Yat-sen University
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-20
- Primary completion
- 2020-11-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.